000 | 01820 a2200493 4500 | ||
---|---|---|---|
005 | 20250516003542.0 | ||
264 | 0 | _c20110106 | |
008 | 201101s 0 0 eng d | ||
022 | _a1099-1492 | ||
024 | 7 |
_a10.1002/nbm.1514 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _ate Boekhorst, B C M | |
245 | 0 | 0 |
_aThe time window of MRI of murine atherosclerotic plaques after administration of CB2 receptor targeted micelles: inter-scan variability and relation between plaque signal intensity increase and gadolinium content of inversion recovery prepared versus non-prepared fast spin echo. _h[electronic resource] |
260 |
_bNMR in biomedicine _cOct 2010 |
||
300 |
_a939-51 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApolipoproteins E _xgenetics |
650 | 0 | 4 |
_aBiomarkers _xmetabolism |
650 | 0 | 4 |
_aGadolinium _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImage Enhancement _xmethods |
650 | 0 | 4 |
_aMagnetic Resonance Imaging _xinstrumentation |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 | _aMicelles |
650 | 0 | 4 |
_aNitric Oxide Synthase Type III _xgenetics |
650 | 0 | 4 |
_aPlaque, Atherosclerotic _xmetabolism |
650 | 0 | 4 |
_aReceptor, Cannabinoid, CB2 _xmetabolism |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTissue Distribution |
700 | 1 | _aBovens, S M | |
700 | 1 | _avan de Kolk, C W A | |
700 | 1 | _aCramer, M J M | |
700 | 1 | _aDoevendans, P A F M | |
700 | 1 | _aten Hove, M | |
700 | 1 | _avan der Weerd, L | |
700 | 1 | _aPoelmann, R | |
700 | 1 | _aStrijkers, G J | |
700 | 1 | _aPasterkamp, G | |
700 | 1 | _avan Echteld, C J A | |
773 | 0 |
_tNMR in biomedicine _gvol. 23 _gno. 8 _gp. 939-51 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/nbm.1514 _zAvailable from publisher's website |
999 |
_c20207474 _d20207474 |